Meningioma growth during interferon beta-1A treatment for multiple sclerosis

Arq Neuropsiquiatr. 2008 Jun;66(2B):402-4. doi: 10.1590/s0004-282x2008000300024.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adjuvants, Immunologic / adverse effects
  • Adjuvants, Immunologic / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Immunohistochemistry
  • Interferon beta-1a
  • Interferon-beta / adverse effects
  • Interferon-beta / therapeutic use*
  • Magnetic Resonance Imaging
  • Meningeal Neoplasms / diagnosis*
  • Meningioma / diagnosis*
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Platelet-Derived Growth Factor / metabolism

Substances

  • Adjuvants, Immunologic
  • Antineoplastic Agents
  • Platelet-Derived Growth Factor
  • Interferon-beta
  • Interferon beta-1a